Johannes M. Heuckmann

Max Planck Society — Germany

Medicine · Health Sciences

28h-index7.0kcitations137works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(105), Cancer therapeutics and mechanisms(49), Lung Cancer Research Studies(23), Colorectal Cancer Treatments and Studies(17), Cancer Genomics and Diagnostics(16)

Publications137 total

Somatic rearrangements causing oncogenic ectodomain deletions of FGFR1 in squamous cell lung cancer
Journal of Clinical Investigation·2023· 9 citedOpen Access
Supplementary Figures 1-7 from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Data from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Supplementary Tables from <i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma
2023Open Access
Supplementary Methods and Legends from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified <i>FGFR1</i> in Lung Cancer
2023Open Access
Supplementary Tables from <i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma
2023Open Access
Supplementary Figures S1-S14 from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified <i>FGFR1</i> in Lung Cancer
2023Open Access
Supplementary Figure Legends 1-7 from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Data from <i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma
2023Open Access
Supplementary Figures from <i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma
2023Open Access
Supplementary Figure Legends 1-7 from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Supplementary Figures S1-S14 from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified <i>FGFR1</i> in Lung Cancer
2023Open Access
Data from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Interview with Dr. Meyerson from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Data from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified <i>FGFR1</i> in Lung Cancer
2023Open Access
Interview with Dr. Meyerson from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Supplementary Table 1 from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Supplementary Figures 1-7 from Mutations in the <i>DDR2</i> Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
2023Open Access
Data from Cell-Autonomous and Non–Cell-Autonomous Mechanisms of Transformation by Amplified <i>FGFR1</i> in Lung Cancer
2023Open Access
Data from <i>CD74–NRG1</i> Fusions in Lung Adenocarcinoma
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Roman K. Thomas(35), Martin Peifer(23), Martin L. Sos(22), Lukas C. Heukamp(20), Daniel Rauh(19), Roopika Menon(18), Mirjam Koker(14), Jürgen Wolf(14), Frauke Leenders(13), Stefanie Heynck(13), William Pao(10), Reinhard Büttner(10), Dennis Plenker(9), Sascha Ansén(9), Matthäus Getlik(9), Jonathan M. Weiss(8), Roland T. Ullrich(8), Sotirios Lakis(8), Thomas Zander(7), Janine Altmüller(7)